Tyra Biosciences, Inc
Tyra Biosciences is a clinical-stage biotechnology company developing oral FGFR inhibitors for oncology and genetically defined conditions.
8-KNov 12Latest SEC filing
Nov 10Latest story
November 2026
September 2026
August 2026
Tyra Biosciences is a clinical-stage biotechnology company developing oral FGFR inhibitors for oncology and genetically defined conditions.
November 2026
September 2026
August 2026